Skip to main content
Premium Trial:

Request an Annual Quote

Ruedi Aebersold, Michael Colvin

Premium

Institute for Systems Biology co-founder Ruedi Aebersold has accepted a position with the Swiss Federal Institute of Technology Zurich (ETH Zurich) to create an interdisciplinary “faculty cluster” focused on systems biology. Aebersold will remain at ISB full-time for the next 18 months, and will move to Switzerland at the end of 2004 or early 2005, where he will serve as professor of systems biology at ETH and as a member of the ISB faculty. He will continue to spend 20-25 percent of his time at ISB, the institute said, where he will focus on “developing computational tools for proteomics, taking advantage of the Institute’s expertise in computational biology.”


The University of California Merced, the tenth and newest campus of the University of California system, has appointed Michael Colvin as professor in the Schools of Natural Sciences and Engineering. Colvin is a leader of the Computational Biology Group in the Biology and Biotechnology Research Program at Lawrence Livermore National Laboratory.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.